| ETF | 价格 / NAV | AUM | 费率 | 折溢价 | 1 年 | 3 年 | 5 年 | 波动率 | 最大回撤 | 最新资金流 | 跟踪误差 | 杠杆路径影响 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XBI State Street SPDR S&P Biotech ETF 行业 | $151.46 NAV $148 | $9.73B | 0.35% | +2.34% | +76.43% | +80.82% | +22.99% | 26.79% | -54.00% | -$1.27B | — | — |
| IBB iShares Biotechnology ETF 其他 | $189.96 NAV $188.64 | $9.09B | 0.44% | +0.70% | +42.44% | +48.14% | +16.07% | 20.35% | -39.82% | -$443.5M | — | — |
| FBT First Trust Amex Biotech Index Fund 行业 | $252.66 NAV $250.36 | $2.81B | 0.55% | +0.92% | +52.41% | +63.27% | +52.57% | 21.17% | -28.98% | -$64.7M | — | — |
| PBPH Portfolio Building Block World Pharma and Biotech Index ETF 行业 | $27.53 NAV $27.88 | $859.4M | 0.13% | -1.26% | — | — | — | 17.92% | -11.10% | +$12.8M | — | — |
| BBH VanEck Biotech ETF 行业 | $208.01 NAV $208.61 | $406.9M | 0.35% | -0.29% | +27.65% | +31.64% | +2.66% | 19.44% | -39.86% | -$1.6M | — | — |
| PBE Invesco Biotechnology & Genome ETF 其他 | $91.1 NAV $91.12 | $277.9M | 0.58% | -0.02% | +41.02% | +46.80% | +23.46% | 18.75% | -34.71% | +$91,489 | — | — |
| IDNA iShares Genomics Immunology and Healthcare ETF 其他 | $32.79 NAV $32.2 | $193.6M | 0.47% | +1.82% | +52.21% | +41.48% | -31.59% | 24.98% | -68.26% | -$1.7M | — | — |
| BBP Virtus Biotech ETF 行业 | $96.49 NAV $96.54 | $96.7M | 0.79% | -0.05% | +56.33% | +75.47% | +90.02% | 23.89% | -37.77% | -$783,826 | — | — |
| GNOM Global X Genomics & Biotechnology ETF 其他 | $55.39 NAV $53.81 | $76.8M | 0.50% | +2.94% | +58.29% | +14.54% | -38.45% | 27.39% | -72.14% | -$4.4M | — | — |
| IBBQ Invesco Nasdaq Biotechnology ETF 宽基 | $32.7 NAV $32.42 | $72.8M | 0.19% | +0.87% | +47.09% | +62.64% | +32.49% | 20.07% | -37.94% | -$4.6M | — | — |
| BBC Virtus Biotech Clinical Trials ETF 行业 | $50.27 NAV $48.48 | $46.0M | 0.79% | +3.69% | +130.98% | +115.12% | +16.22% | 36.41% | -70.92% | -$2.2M | — | — |
| BIOY GraniteShares YieldBOOST Biotech ETF 行业 | $21.64 NAV $21.22 | $638,000 | 1.07% | +1.98% | — | — | — | 18.03% | -6.66% | -$16,185 | — | — |
每日资金流由 AUM、收益和份额变化估算；公开源无法统一得到实际申购/赎回单位时明确显示“未披露”，不会把估算冒充成交。
完整持仓使用 SEC N-PORT 法定申报，覆盖面广但有监管披露时滞；Yahoo 前十大持仓只用于更及时的概览。
收益使用复权收盘价。跟踪误差只有明确基准映射时计算；杠杆衰减拆分为每日复位路径影响和实现偏差。